XFOR X4 Pharmaceuticals Inc. Net Profit Rate

X4 Pharmaceuticals Inc. (XFOR) - corporate logo

The investment potential of X4 Pharmaceuticals (XFOR) depends on the successful market launch of its first drug, where revenue uncertainty creates certain risks. The current sales margin level illustrates the business's adaptation to borrowing costs, while -474.70 reflects the metric's baseline. Stable demand for rare pathology therapies guarantees a long-term monopoly, and a mature pipeline of oral CXCR4 inhibitors confirms the company's technological readiness.

Net Sales Margin: X4 Pharmaceuticals (XFOR) for 07/04/2022 - 11/19/2026

Financial and market metric breakdowns for X4 Pharmaceuticals, Inc (XFOR)

Fundamental valuation:x4pharma.com, XFOR
Flagship merchandise of X4 Pharma

Sales margins determine the share of net profit in every dollar of revenue, signaling the efficiency of cost management. This indicator aggregates operating expenses and taxes, reflecting the final profitability of the business through current net profit margins. A drop in this metric below zero warns of critical losses and capital risk. For X4 Pharmaceuticals (XFOR), this metric will become key during the commercial launch of Xolremdi. An increase in profitability will confirm the successful scaling of the CXCR4 inhibitor pipeline.

Competitor analysis

argenx (ARGX) - Net Margin|BNTX - Company Sales Margin|ABVX (Abivax Pharma) - Net Sales Margin|Return on Sales by Net Profit ADMA Bio (ADMA)|Return on Sales by Net Profit PTGX (Protagonist Therapeutics Inc)|Net Sales Margin immunovant.com (IMVT)|Net Margin kiniksa.com KNSA|Grifols SA (GRFS) - Net Margin|Adaptive Biotechnologies Inc. - Net Sales Margin|Net Margin Celldex Therapeutics|AUPH: Net Sales Margin|BCRX - Company Sales Margin|VERA (Vera Corp) - Net Sales Margin|Dianthus Pharma (DNTH) - Company Sales Margin|Net Margin Pharvaris Pharma (PHVS)|Net Sales Margin AbCellera Corp (ABCL)|Net Sales Margin TRML (Tourmaline Bio Inc)|Company Sales Margin precigen.com (PGEN)|PHAR - Net Margin|Net Profit Rate NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio Corp) - Return on Sales by Net Profit|Zenas Corp (ZBIO) - Net Sales Margin|Return on Sales by Net Profit IMNM|GOSS: Net Profit Rate|Net Margin KalVista Pharma (KALV)|SEPN - Net Margin|Net Sales Margin PVLA (pieris.com)|Net Sales Margin Savara Pharma SVRA|RIGL: Return on Sales by Net Profit|ANAB - Net Sales Margin|ATXS: Net Sales Margin|ENGN - Company Sales Margin|Return on Sales by Net Profit RAPT|JBIO (Aerovate Therapeutics Inc) - Company Net Profitability|Net Sales Margin ACRS|Return on Sales by Net Profit kyvernatx.com KYTX|Net Sales Margin TLSA (Tiziana Life Sciences, Ltd.)|Net Sales Margin Cabaletta Bio CABA|VTYX: Return on Sales by Net Profit|Theratechnologies Inc. (THTX) - Return on Sales by Net Profit|AVTX: Net Sales Margin|ELDN - Company Sales Margin|AGEN (Agenus, Inc) - Net Sales Margin|Net Sales Margin Climb Bio, Inc.|Net Margin Zura Bio Limited (ZURA)|ATYR (aTyr Pharmaceuticals) - Net Profit Rate|Net Sales Margin ADAG (Adagene Inc)|IMA - Return on Sales by Net Profit|STTK - Net Margin|EQ (equilliumbio.com) - Net Return on Sales|CNTB: Net Sales Margin|Immunic Inc (IMUX) - Net Sales Margin|ATRA (Atara Biotherapeutics Inc) - Net Sales Margin|Net Return on Sales IFRX (InflaRx N.V.)|Net Sales Margin ACET|Return on Sales by Net Profit Celularity Corp CELU|INmune Bio Inc - Return on Sales by Net Profit|BRNS (Barinthus Bio) - Net Profit Margin|KZR - Net Margin|Company Sales Margin sabbiotherapeutics.com SABS|Akari Therapeutics PLC (AKTX) - Net Margin|ENLV - Company Sales Margin|QTTB (Q32 Bio) - Net Sales Margin|Net Margin GeoVax Labs Inc GOVX|Net Margin Edesa Biotech (EDSA)|Return on Sales by Net Profit iBio IBIO|Carisma Therapeutics Inc - Return on Sales by Net Profit|XTLB - Return on Sales by Net Profit|BOLT - Net Margin|Net Profit Rate HCWB (hcwbiologics.com)|APVO: Net Sales Margin|aimimmuno.com (AIM) - Net Sales Margin|Net Margin aditxt.com|Return on Sales by Net Profit GRI Bio Corp (GRI)|Net Margin XORTX Therapeutics Inc. (XRTX)|Return on Sales by Net Profit ReShape Lifesciences HIND|Net Margin Revelation Biosciences REVB|INDP: Net Return on Sales|SCNI - Net Margin|CALI (calcimedica.com) - Net Return on Sales|AFMD (Affimed Therapeutics) - Return on Sales by Net Profit|Allakos Therapeutics (ALLK) - Net Sales Margin|HOOK (HOOKIPA) - Net Sales Margin|igmbio.com (IGMS) - Company Sales Margin|Net Sales Margin ITOS|OCEA (Ocean Biomedical) - Net Profit Rate|Net Sales Margin TCBP (TC BioPharm (Holdings) PLC)|THRD - Return on Sales by Net Profit